
Sign up to save your podcasts
Or


Dr Enriqueta Felip from the Vall d’Hebron Institute of Oncology in Barcelona, Spain, and Dr Helena Yu from Memorial Sloan Kettering Cancer Center in New York, New York, discuss current and emerging treatment approaches for patients with EGFR-mutant non-small cell lung cancer.
CME information and select publications here
By Dr. Neil Love4.4
3030 ratings
Dr Enriqueta Felip from the Vall d’Hebron Institute of Oncology in Barcelona, Spain, and Dr Helena Yu from Memorial Sloan Kettering Cancer Center in New York, New York, discuss current and emerging treatment approaches for patients with EGFR-mutant non-small cell lung cancer.
CME information and select publications here

43,653 Listeners

317 Listeners

2,060 Listeners

68 Listeners

73 Listeners

14 Listeners

17 Listeners

12 Listeners

0 Listeners

120 Listeners

58 Listeners

45 Listeners

26 Listeners

57 Listeners

192 Listeners

43 Listeners

0 Listeners

3 Listeners